These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22378151)

  • 21. Does osteocytic SOST suppression mediate PTH bone anabolism?
    Kramer I; Keller H; Leupin O; Kneissel M
    Trends Endocrinol Metab; 2010 Apr; 21(4):237-44. PubMed ID: 20074973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxyapatite nanorods loaded with parathyroid hormone (PTH) synergistically enhance the net formative effect of PTH anabolic therapy.
    Dave JR; Dewle AM; Mhaske ST; Phulpagar PT; Mathe VL; More SE; Khan AA; Murthy AVR; Datar SS; Jog AJ; Page M; Tomar GB
    Nanomedicine; 2019 Jan; 15(1):218-230. PubMed ID: 30343014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging anabolic treatments in osteoporosis.
    Mosekilde L; Tørring O; Rejnmark L
    Curr Drug Saf; 2011 Apr; 6(2):62-74. PubMed ID: 21524248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis.
    Adami G; Orsolini G; Adami S; Viapiana O; Idolazzi L; Gatti D; Rossini M
    Calcif Tissue Int; 2016 Oct; 99(4):360-4. PubMed ID: 27307275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.
    Sawakami K; Robling AG; Ai M; Pitner ND; Liu D; Warden SJ; Li J; Maye P; Rowe DW; Duncan RL; Warman ML; Turner CH
    J Biol Chem; 2006 Aug; 281(33):23698-711. PubMed ID: 16790443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.
    Merciris D; Marty C; Collet C; de Vernejoul MC; Geoffroy V
    Am J Pathol; 2007 May; 170(5):1676-85. PubMed ID: 17456773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preactivation of β-catenin in osteoblasts improves the osteoanabolic effect of PTH in type 1 diabetic mice.
    Chen S; Yang L; He S; Yang J; Liu D; Bao Q; Qin H; Du W; Zhong X; Chen C; Zong Z
    J Cell Physiol; 2020 Feb; 235(2):1480-1493. PubMed ID: 31301073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling.
    Siddiqui JA; Le Henaff C; Johnson J; He Z; Rifkin DB; Partridge NC
    Bone; 2021 Feb; 143():115762. PubMed ID: 33212319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
    Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
    J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anabolic action of PTH under the loading/unloading condition].
    Sakai A
    Clin Calcium; 2012 Mar; 22(3):365-71. PubMed ID: 22370303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
    von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
    J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anabolic effects of intermittent PTH on osteoblasts.
    Greenfield EM
    Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH.
    Yuan Q; Sato T; Densmore M; Saito H; Schüler C; Erben RG; Lanske B
    J Bone Miner Res; 2011 Sep; 26(9):2026-35. PubMed ID: 21590742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.
    Yao W; Cheng Z; Shahnazari M; Dai W; Johnson ML; Lane NE
    J Bone Miner Res; 2010 Feb; 25(2):190-9. PubMed ID: 19594295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Levels of Dickkopf-Related Protein 1 Decrease as Measured GFR Declines and Are Associated with PTH Levels.
    Forster CM; White CA; Turner ME; Norman PA; Ward EC; Hopman WM; Adams MA; Holden RM
    Am J Nephrol; 2020; 51(11):871-880. PubMed ID: 33238271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anabolic action of parathyroid hormone regulated by the β2-adrenergic receptor.
    Hanyu R; Wehbi VL; Hayata T; Moriya S; Feinstein TN; Ezura Y; Nagao M; Saita Y; Hemmi H; Notomi T; Nakamoto T; Schipani E; Takeda S; Kaneko K; Kurosawa H; Karsenty G; Kronenberg HM; Vilardaga JP; Noda M
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7433-8. PubMed ID: 22538810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms involved in skeletal anabolic therapies.
    Martin TJ; Quinn JM; Gillespie MT; Ng KW; Karsdal MA; Sims NA
    Ann N Y Acad Sci; 2006 Apr; 1068():458-70. PubMed ID: 16831943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation.
    Guo J; Liu M; Yang D; Bouxsein ML; Saito H; Galvin RJ; Kuhstoss SA; Thomas CC; Schipani E; Baron R; Bringhurst FR; Kronenberg HM
    Cell Metab; 2010 Feb; 11(2):161-71. PubMed ID: 20142103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disuse in adult male rats attenuates the bone anabolic response to a therapeutic dose of parathyroid hormone.
    Turner RT; Lotinun S; Hefferan TE; Morey-Holton E
    J Appl Physiol (1985); 2006 Sep; 101(3):881-6. PubMed ID: 16675609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
    Rossini M; Gatti D; Adami S
    Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.